Intraokulare Entzündungen bei Brolucizumab-Anwendung: Patientenmanagement – Diagnose – Therapie

por Holz, F. G., Heinz, C., Wolf, A., Hoerauf, H., Pleyer, U.
Publicado 2021

Clinico-pathological correlation of lacrimal caruncle tumors: a retrospective analysis over 22 years at the University Eye Hospital Bonn

por Clemens, A. C., Loeffler, K. U., Holz, F. G., Herwig-Carl, M. C.
Publicado 2021

Long-term outcomes of phakic patients with diabetic macular oedema treated with intravitreal fluocinolone acetonide (FAc) implants

por Yang, Y, Bailey, C, Holz, F G, Eter, N, Weber, M, Baker, C, Kiss, S, Menchini, U, Ruiz Moreno, J M, Dugel, P, Lotery, A
Publicado 2015

Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study

por Holz, F G, Tadayoni, R, Beatty, S, Berger, A R, Cereda, M G, Hykin, P, Staurenghi, G, Wittrup-Jensen, K, Nilsson, J, Kim, K, Sivaprasad, S
Publicado 2016

A randomized, open-label, multicenter study of switching to brolucizumab with or without a loading dose for patients with suboptimal anatomically controlled neovascular age-related...

por Holz, F. G., Schmitz-Valckenberg, Steffen, Wolf, A., Agostini, H., Lorenz, K., Pielen, A., Feltgen, N., Guthoff, R., Quiering, C., Clemens, A., Jaeger, K.
Publicado 2022